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The use of animal models in the study of infectious 
diseases can make a valuable contribution to finding 
ways of treating human and animal diseases that occur 
in the world today. Such models will involve studying 
the processes involved in specific infections, as well as 
the development of vaccines and antimicrobial drugs, 
and measuring their effectiveness. Having said that, it 
must be ensured that the use of animals is essential 
and that appropriate models are used, and that other 
methods not involving animals cannot be used (in fact, 
very often both in vitro and in vivo methods are used, 
as they answer different questions). 
Despite the fact that this use of animals provides 
useful and important information about many aspects 
of a disease and its cure, the public is still concerned at 
the ways in which animals are used in research. This 
reflects a general concern over animal welfare and is not 
confined to those used in research, but also includes, for 
example, farming, sport, wild animals, zoos and circuses 
111. There is a general view that it is wrong to cause 
animals pain and suffering, and so the deliberate inflic- 
tion of suffering for no good purpose is described as 
‘cruelty’ and is an offence in many countries. Animal 
research causes pain and suffering but it is considered 
acceptable because of the benefits that come from it. 
However, that does not mean that scientists can do 
anything to animals in the name of science. There are 
perhaps four crucial points to consider: the purpose of 
the experiment should be a good one with significant 
benefit; any animal suffering should be avoided or 
always be the minimum necessary to achieve the scien- 
tific objective; any animal suffering should be com- 
mensurate with the potential benefits; and it should be 
noted that there are strong scientific reasons to reduce 
animal suffering because the suffering itself may give 
rise to misleading research results which ultimately may 
result in more animals being used than necessary. 
Avoidable animal suffering can occur as a result of 
poor husbandry, routine scientific procedures carried 
out incompetently (such as restraint, transport, in- 
jections), and poor experimental design. The resultant 
adverse physiologic and psychological responses of the 
animal will lead, amongst other things, to a release of 
corticosteroids which may well suppress the immune 
system, making animals less suitable for the research 
into infection, or even die. This only adds further 
unnecessary expense to the cost of research in terms of 
animals, scientists’ time and consumables because of 
the misleading results. Furthermore, it is inhumane to 
cause avoidable suffering and to use more animals than 
necessary. 
So does research into infection cause particular 
ethical problems and can the standards of animal 
research in this area be improved? A look at it from the 
animals’ viewpoint, as opposed to the scientific 
viewpoint, may highlight some areas where 
improvements could be made with little or no financial 
cost, and with benefit to the science as well as to the 
animals. First, there are some general points to consider. 
Some models of infection are clearly better than others, 
and a model must do more than simply mimic the 
clinical signs of that disease in humans. Ideally, it should 
have the same pathogenesis as the human disease, the 
microorganism should infect and progress in a similar 
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nianner, the immune response should be similar, and 
infection should result in similar sequelae and prog- 
noses. As more becomes known about the genetic 
variability of humans and microorganisms, so it should 
be possible to devise better animal models and strategies 
for dealing with infectious (and non-infectious) diseases, 
e.g. using transgenic animals, gene knock-out animals, 
and genetically modified microorganisms. 
Before work goes ahead, several other questions 
may be asked in order to ensure that humane research 
is being carried out. For example, is it possible to do 
the work in vitro; is the proposed model the best one 
available to answer the scientific question; can a less 
sentient species be used; are the facilities appropriate for 
the work and are there adequate staff to monitor the 
animals at critical times, e.g. when they are likely to die 
so that they can be humanely killed; is the experiment 
well designed; could more information be gained with 
a different design or statistical analysis; are pilot studies 
required, such as dose sighting; are the endpoints clearly 
defined, recognizable and humane, so that animals can 
be killed when they are no longer useful scientifically, 
or when the suffering is not justified by the potential 
benefit [2]. These sort of questions should be posed and 
advice taken before going ahead with the in vivo animal 
model. Kussell and Burch [3]  summed this approach up 
as the ‘Three Ks’: replacement, reduction and refine- 
ment. Respectively, these are: to replace animals with 
in vitro methods wherever possible; to use as few 
animals as possible (although it is just as wrong to use 
too few animals in research as it is to use too many, and 
so round statistical advice should be sought); and to 
cause as little suffering as necessary to achieve the 
scientific objective, i.e. not to cause avoidable suffering. 
Refinement comprises those methods which alle- 
viate or minimize the potential pain, distress or other 
adverse effects suffered by the animals involved, or 
methods by which animal wellbeing can be enhanced, 
whilst retaining the scientific objective [4]. However, 
before one can start to refine an experiment, one has 
to be able to recognize when animals are suffering. 
Once animal suffering has been recognized, it becomes 
possible to assess it and to make changes in order to 
avoid, alleviate and reduce it. 
At the University of Birmingham we are develop- 
ing an assessment sheet recording system for measuring 
adverse effects on an animal during an experiment 
[S-71. These sheets are specifically drawn up for each 
experimental model and for each species. Basically, 
the sheets record clinical signs observed over time. 
They encourage animal care-takers and researchers to 
recognize and assess signs of animal suffering such as 
pain, discomfort and distress. They provide a complete 
record of the effects of the scientific procedure on 
animals and encourage all involved in the research to 
observe the behavior of animals, and to recognize 
normal and abnormal behaviors. They help train new 
and old technicians by raising the awareness of all those 
involved in the experiment and they are especially 
useful with new procedures when users are not always 
sure ofwhat effects they will have. Finally, the sheet can 
help to refine and to devise humane endpoints [ 8 ] .  
The European Experimental Infection Ethics Coni- 
mittee, under the Chairmanship of Professor Claude 
Carbon, was set up to start to look at determining best 
practice in various models of infection, i.e. to apply the 
Three Ks. The Committee has produced one model of 
best practice for endocarditis, and we hope to produce 
others in the near future. 
In conclusion, I hope to have explained why it is 
iniportant to refine animal experinients so that animal 
suffering is reduced to the minimum for reasons 
relating to humane and responsible science, as well 
as good science. Such an approach provides for an 
effective use of scarce research resources. It  is also 
important that animal models are fully written up in 
scientific journals so that best practices can be dis- 
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